Oxidation of heparin-treated low density lipoprotein by peroxidases

被引:19
作者
Upritchard, JE
Sutherland, WHF
机构
[1] Univ Otago, Sch Med, Dept Med, Dunedin, New Zealand
[2] Univ Otago, Dept Human Nutr, Sch Med, Dunedin, New Zealand
关键词
peroxidases; low density lipoproteins; heparin; glycosaminoglycans; antioxidants; serum inhibitors;
D O I
10.1016/S0021-9150(99)00127-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low density lipoproteins (LDL) can bind to glycosaminoglycans and proteoglycans rich in heparin and chondroitin sulphate in the arterial intima and may become a target for atherogenic modification by myeloperoxidase activity. We have examined the susceptibility of resolubilized LDL, that has been precipitated from serum with heparin (HepLDL), to peroxidase-H2O2-catalysed oxidation and the effects of antioxidants and components of human serum on the oxidation. HepLDL was oxidised rapidly by horse radish peroxidase (HRP) and H2O2 (mean t(1/2max) for conjugated diene formation, 3 min) while there was little oxidation of native LDL or native LDL precipitated with polyethyleneglycol and resolubilised during the 30 min incubation period. The formation of thiobarbituric acid reacting substances (TBARS) essentially paralleled that of conjugated dienes during oxidation of HepLDL. HepLDL was also more rapidly oxidised than native LDL by myeloperoxidase-H2O2. Oxidation of HepLDL by peroxidases did not require free tyrosine. was almost totally inhibited by butylated hydroxytoluene (BHT) and ascorbate, and was unaffected by vitamin E and urate. Increasing concentrations (0-14.9%) of beta-lipoprotein deficient serum (BLPDS) significantly (P<0.0001) inhibited the formation of TEARS during HepLDL oxidation catalysed by HRP and partially inhibited the corresponding myeloperoxidase-catalysed oxidation. This inhibitory activity was removed by dialysis and gel-filtration of BLPDS and was not restored by addition of magnesium ions used in the isolation of BLPDS, or physiological levels of ascorbate, tyrosine and reduced thiols (cysteine) to Eel-filtered BLPDS. The results indicate that LDL from complexes with glycosaminoglycans are highly susceptible to oxidation by peroxidases, particularly at low levels of water soluble antioxidants, and that vulnerability of these LDL to myeloperoxidase oxidation remains in the presence of serum components that should exist in the arterial intima. These findings may be relevant to the oxidative modification of LDL that becomes trapped by binding to arterial proteoglycans and to the formation of myeloperoxidase-modified LDL in the artery wall. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:211 / 219
页数:9
相关论文
共 39 条
[1]   The role of oxidized lipoproteins in atherogenesis [J].
Berliner, JA ;
Heinecke, JW .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (05) :707-727
[2]  
Beuge J.A., 1978, METHOD ENZYMOL, V52, P302
[3]   STRUCTURE OF LOW-DENSITY LIPOPROTEIN IN COMPLEXES FORMED WITH ARTERIAL MATRIX COMPONENTS [J].
BIHARIVARGA, M ;
CAMEJO, G ;
HORN, MC ;
SZABO, D ;
LOPEZ, F ;
GRUBER, E .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1983, 5 (01) :59-62
[4]   TOCOPHEROL-MEDIATED PEROXIDATION - THE PROOXIDANT EFFECT OF VITAMIN-E ON THE RADICAL-INITIATED OXIDATION OF HUMAN LOW-DENSITY-LIPOPROTEIN [J].
BOWRY, VW ;
STOCKER, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (14) :6029-6044
[5]   MODIFICATIONS OF LOW-DENSITY-LIPOPROTEIN INDUCED BY ARTERIAL PROTEOGLYCANS AND CHONDROITIN-6-SULFATE [J].
CAMEJO, G ;
HURT, E ;
WIKLUND, O ;
ROSENGREN, B ;
LOPEZ, F ;
BONDJERS, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1096 (03) :253-261
[6]   Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis [J].
Camejo, G ;
Hurt-Camejo, E ;
Wiklund, O ;
Bondjers, G .
ATHEROSCLEROSIS, 1998, 139 (02) :205-222
[7]  
CAMEJO G, 1985, BIOMED BIOCHIM ACTA, V44, P389
[8]  
CAMEJO G, 1991, J LIPID RES, V32, P1983
[9]   HUMAN SUCTION BLISTER INTERSTITIAL FLUID PREVENTS METAL ION-DEPENDENT OXIDATION OF LOW-DENSITY-LIPOPROTEIN BY MACROPHAGES AND IN CELL-FREE SYSTEMS [J].
DABBAGH, AJ ;
FREI, B .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1958-1966
[10]   MYELOPEROXIDASE, A CATALYST FOR LIPOPROTEIN OXIDATION, IS EXPRESSED IN HUMAN ATHEROSCLEROTIC LESIONS [J].
DAUGHERTY, A ;
DUNN, JL ;
RATERI, DL ;
HEINECKE, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :437-444